Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2007
08/02/2007US20070179173 Carbostyril compound
08/02/2007US20070179159 1-(3,4,5-trimethoxy-phenyl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; 1-(2-hydroxy-4-methoxy-5-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-(4-bromo-phenyl)-1H-[1,2,3]triazole; inhibits tubulin polymerization in a cell; cancer
08/02/2007US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
08/02/2007US20070179144 5(Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
08/02/2007US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/02/2007US20070179139 Methyl 4-{[(2-{4-[(4-bromophenoxy)methyl]-2,5-dimethyl-3-thienyl}ethyl)(5-ethoxy-5-oxopentyl)amino]methyl}benzoate, for example; treatment of cardiovascular and other diseases
08/02/2007US20070179137 Screening of anti-viral drugs and pharmaceuticals composition containing thiazolidinone derivatives
08/02/2007US20070179133 Compositions useful as inhibitors of protein kinases
08/02/2007US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
08/02/2007US20070179129 Opioid receptor antagonists
08/02/2007US20070179126 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
08/02/2007US20070179125 Aminopyrimidines useful as kinase inhibitors
08/02/2007US20070179122 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
08/02/2007US20070178512 Modified carbocyanine dyes and their conjugates
08/02/2007US20070178511 Modified carbocyanine dyes and their conjugates
08/02/2007US20070176541 Organic light emitting compound and organic light emitting device comprising the same
08/02/2007CA2640213A1 2-[6-(methylamino)pyridine-3-yl]-1,3-benzothiazole-6-ol for measuring an anyloid deposit
08/02/2007CA2637933A1 Indole sulfonamide modulators of progesterone receptors
08/02/2007CA2627607A1 Fap inhibitors
08/01/2007EP1813651A1 Optical filter
08/01/2007EP1813612A1 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]b enzyl]thiazolidine-2,4-dione
08/01/2007EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
08/01/2007EP1812451A2 Compounds and methods of use thereof
08/01/2007EP1812432A2 Combination of a src kinase inhibitor and a bcr-abl inhibitor for the treatment of proliferative diseases
08/01/2007EP1812431A1 4-(pyrazine-2-yl)-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
08/01/2007EP1812430A1 Substituted phenylaminothiazoles and use thereof
08/01/2007EP1812406A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
08/01/2007EP1812405A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs
08/01/2007EP1812400A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
08/01/2007EP1811993A2 Modulators of crth2, cox-2 and faah
08/01/2007EP1687300A4 Process for the preparing ziprasidone monohydrochloride hydrate
08/01/2007EP1581528B1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
08/01/2007EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors
08/01/2007EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/01/2007EP1484327B1 Nitrogenous heterocyclic compound and medicine thereof
08/01/2007EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
08/01/2007EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands
08/01/2007EP1294714B1 Thrombin receptor antagonists
08/01/2007CN1329386C Substituted phenylacetamides and their use as glucokinase activators
08/01/2007CN1329378C Compounds useful to treat retroviral infections
08/01/2007CN1329375C Novel anti-diabetic agents
08/01/2007CN101010319A Indole derivatives, their manufacture and use as pharmaceutical agents
08/01/2007CN101010316A Compounds useful for inhibiting CHK1
08/01/2007CN101010301A 5-HT7 receptor antagonosts
08/01/2007CN101007804A 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses
07/2007
07/31/2007US7250515 Such as 6-[2-(2,2-difluoro-2-pyridin-2-yl-ethylamino)-4-oxo-4H-thiazol-(5Z)-ylidenemethyl]-4-ethoxy-quinoline-3-carbonitrile; demonstrate CDK1 antiproliferative activity, useful as anti-cancer agent.
07/31/2007US7250508 Cefdinir intermediate
07/31/2007US7250442 glucocorticoid, androgen, mineralcorticoid, estrogen and progesterone receptor modulators such as 3,3-Bis-(4-hydroxy-3,5-dimethyl-phenyl)-1-(4-methoxy-benzyl)-1,3-dihydro-indol-2-one, used for treating congestive heart failure
07/31/2007US7250431 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide
07/31/2007US7250421 Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
07/31/2007US7250418 Corticotropin releasing factor antagonist; antiinflammatory agents; drug abuse; analgesics; antihistamines; skin disorders; neurodegenerative disease; eating disorders;eating disorders; antiepileptic agents; cardiovascular disorders
07/31/2007CA2333603C New dipeptidyl peptidase iv effectors
07/31/2007CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/31/2007CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
07/26/2007WO2007084914A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
07/26/2007WO2007084786A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
07/26/2007WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders
07/26/2007WO2007084391A2 Thiazole compounds as protein kinase b ( pkb) inhibitors
07/26/2007WO2007083732A1 Optical recording medium and azo metal chelate compound
07/26/2007WO2007083207A1 Substituted imidazoles and their use as pesticides
07/26/2007WO2007083187A2 An improved process for the preparation of monobactam antibiotic
07/26/2007WO2007082956A1 Thiazole derivatives and use thereof
07/26/2007WO2007082873A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
07/26/2007WO2007082666A1 Acylaminoimidazoles
07/26/2007WO2007054292A3 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom
07/26/2007WO2007022501A3 Useful indole compounds
07/26/2007US20070173641 Azotization of 5-amino-3-t-butyl-4-cyanopyrazole, then reacting with couplers and alkylation or arylation, to form azo dyes, used as inks having colorfastness; liquid crystal displays and plasma display panels; excellent color reproducibility
07/26/2007US20070173516 Pyrazine kinase inhibitors
07/26/2007US20070173507 Dairyl-substituted five-membered heterocycle derivative
07/26/2007US20070173506 Thiazole compounds and methods of use
07/26/2007US20070173504 Calcium channel antagonists
07/26/2007US20070173494 Diaza heterocyclic sulfonamide derivatives and their uses
07/26/2007US20070173491 Substituted lactams as inhibitors of Abeta protein production
07/26/2007US20070173489 antagonists of the interaction between the plasma protein von Willebrand factor (vWF) and the blood platelet receptor glycoprotein Ib-IX-V complex, exhibit anticoagulant effect and are suitable for the therapy and prophylaxis of cardiovascular disorders
07/26/2007US20070172421 Substituted pyrrolidine-2-ones
07/26/2007CA2637385A1 Compounds for the treatment of inflammatory disorders
07/26/2007CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders
07/26/2007CA2637057A1 Diaryl piperidines as cb1 modulators
07/26/2007CA2636993A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
07/26/2007CA2636916A1 Methods for treating hepatitis c
07/26/2007CA2636905A1 Methods for treating hepatitis c
07/26/2007CA2635830A1 Thiazole derivatives and use thereof
07/26/2007CA2630273A1 Heterocyclylalkyl derivatives as inhibitors of histone deacetylase
07/25/2007EP1810972A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof
07/25/2007EP1810970A1 Therapeutic piperazine compounds
07/25/2007EP1809624A1 Pyrimidine sulphonamide derivatives as chemokine receptor modulators
07/25/2007EP1809299A2 Phosphonate substituted kinase inhibitors
07/25/2007EP1809282A2 Thiadiazole compounds and methods of use
07/25/2007EP1809280A2 Mitotic kinesin inhibitors and methods of use thereof
07/25/2007EP1658272B1 Novel gamma-secretase inhibitors
07/25/2007EP1581207A4 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
07/25/2007EP1558581A4 Triazolone and triazolethione derivatives
07/25/2007EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
07/25/2007EP1389190B1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
07/25/2007EP1325000B1 A thiazolidinedione derivative and its use as antidiabetic
07/25/2007EP1322710B9 Modified carbocyanine dyes and their conjugates
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use
07/25/2007CN1328261C Uracil compounds and their use
07/25/2007CN101006755A White light-emitting electroluminescent device